(function(){var loadHandler=window['sl_{72C0429F-FC8A-44E7-B152-D6826999A52C}'];loadHandler&&loadHandler(160, '<div id="spr0_42c20b64"><div id="spr1_42c20b64" class="kern slide"><img id="img1_42c20b64" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_42c20b64" class="kern slide"><div id="spr3_42c20b64" style="left:64.125px;top:156.882px;"><img id="img0_42c20b64" src="data/img213.png" width="591.75" height="366" alt=""/></div><div id="spr4_42c20b64" style="top:-0.041px;"><div style="width:0px;"><span id="txt0_42c20b64" data-width="430.718750" style="left:40.636px;top:-0.448px;">Combining endocrine treatments</span></div><div style="width:0px;"><span id="txt1_42c20b64" data-width="270.218750" style="left:121.591px;top:37.952px;">with targeted agents</span></div></div><div id="spr5_42c20b64" style="left:253.046px;top:518.189px;"><div style="width:0px;"><span id="txt2_42c20b64" class="relpos" data-width="62.455078" style="left:7.2px;top:2.082px;">Turner et al. </span><span id="txt3_42c20b64" class="relpos" data-width="24.328125" style="left:7.195px;top:2.082px;">2015</span><span id="txt4_42c20b64" class="relpos" style="left:7.19px;top:2.082px;"> </span><span id="txt5_42c20b64" class="relpos" data-width="108.257813" style="left:7.185px;top:2.082px;">N Engl J Med. 373:209</span></div></div><div id="spr6_42c20b64" style="top:91.063px;"><div style="width:0px;"><span id="txt6_42c20b64" data-width="489.083984" style="left:116.525px;top:0.058px;">Fulvestrant + Palbociclib (CDK4/6 inhibitor)</span></div><div style="width:0px;"><span id="txt7_42c20b64" data-width="194.619141" style="left:262.91px;top:34.67px;">Advanced breast cancer</span></div></div></div></div>');})();